Bridging Radiotherapy to Immunotherapy: The IFN–JAK–STAT Axis

The unprecedented successes of immunotherapies (IOs) including immune checkpoint blockers (ICBs) and adoptive T-cell therapy (ACT) in patients with late-stage cancer provide proof-of-principle evidence that harnessing the immune system, in particular T cells, can be an effective approach to eradicat...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Lewis Zhichang Shi, James A. Bonner
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
JAK
Acceso en línea:https://doaj.org/article/186df8d319744d2c830cfb34d6ea2a78
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!